期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Low dose hormone therapy in reproductive endocrinology in China 被引量:1
1
作者 葛秦生 肖碧莲 +1 位作者 乌毓明 李晓红 《Chinese Medical Journal》 SCIE CAS CSCD 2003年第9期1418-1420,共3页
The human endocrine system normally functions in abalanced physiological state. Any excess or deficiencywill cause an endocrine imbalance and result in hyper-orhypo-function, requiring readjustment by hormonesuppressi... The human endocrine system normally functions in abalanced physiological state. Any excess or deficiencywill cause an endocrine imbalance and result in hyper-orhypo-function, requiring readjustment by hormonesuppression or supplementation in order to reestablish anormal physiological balance. 展开更多
关键词 in on of IT AS for Low dose hormone therapy in reproductive endocrinology in China GNRHA
原文传递
DEVELOPMENT OF FEMALE REPRODUCTIVE ENDOCRINOLOGY IN CHINA
2
作者 张丽珠 《Chinese Medical Journal》 SCIE CAS CSCD 1994年第3期5-8,共4页
Female reproductive endocrinology plays an important role in obstetrics and gynecology, and is a component part of perinatology, family planning and geriatrics. It is closely linked with the physiological changes, dis... Female reproductive endocrinology plays an important role in obstetrics and gynecology, and is a component part of perinatology, family planning and geriatrics. It is closely linked with the physiological changes, disease conditions and health care in different reproductive stages of a woman’s life. Ovarian function consists of ovulation and hormonal secretion, which acts upon the uterine endometrium and other target organs and feeds back to the hypothalamus-pituitary unit. Thus, it is connected with other endocrine systems, cerebral cortex and the external environment. Whether the ovrian function is normal or not reflects itself clinically in the changes of menstrual cycle and reproductive status and may be evaluated by laboratory assays. 展开更多
关键词 In DEVELOPMENT OF FEMALE reproductive endocrinology IN CHINA
原文传递
Ovarian hyperstimulation syndrome following the use of GnRH agonist trigger of final oocyte maturation and freeze-all strategy: A case report and review of the literature
3
作者 Dalia Khalife Suleiman Ghunaim +3 位作者 Lina El Taha Omar Odeh Natasha Habr Johnny Awwad 《Asian pacific Journal of Reproduction》 2022年第6期292-298,共7页
Rationale:The current literature has a surprising controversy regarding the use of low-dose human chorionic gonadotropin(hCG)for luteal support as an explanation for the development of ovarian hyperstimulation syndrom... Rationale:The current literature has a surprising controversy regarding the use of low-dose human chorionic gonadotropin(hCG)for luteal support as an explanation for the development of ovarian hyperstimulation syndrome,and this is because of the gap in the listing of the predisposing factors that put women at an increased risk of ovarian hyperstimulation syndrome.Patient concerns:A case of 25-year-old woman presented with abdominal pain,distention,dyspnea,and nausea with a 6.5 kg increase in weight from baseline.Ultrasonographic examination showed bilaterally enlarged multicystic ovaries after gonadotropin-releasing hormone(GnRH)agonist triggering and cycle segmentation with no hCG rescue administration.Diagnosis:Moderate/severe ovarian hyperstimulation syndrome.Interventions:The woman was admitted to the hospital for medical management of moderate/severe ovarian hyperstimulation syndrome,and pain management was advanced to patient-controlled anesthesia with the start of low molecular weight heparin.On day 2,albumin therapy followed by a furosemide chase was started due to an increase in abdominal girth.On day 1,Cabergoline was maintained,and on day 2 the GnRH antagonist Cetrorelix was started.Outcomes:The woman’s clinical condition improved,and a clinical pregnancy was eventually achieved during the first cryo-warmed blastocyst cycle.Lessons:Ovarian hyperstimulation syndrome can still happen even after the use of GnRH agonist and avoidance of hCG support.Segmentation of in vitro fertilization with complete avoidance of hCG for luteal support remains the best approach. 展开更多
关键词 Ovarian hyperstimulation syndrome Gonadotropin releasing hormone agonist In vitro fertilization Human chorionic gonadotropin support Ovulation induction reproductive endocrinology
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部